Association analysis of NAD(P)Hratioquinone oxidoreductase (NQO1) Pro187Ser genetic polymorphism and tardive dyskinesia in patients with schizophrenia in Taiwan.
Liou
Ying-Jay
YJ
Wang
Ying-Chieh
YC
Lin
Chao-Cheng
CC
Bai
Ya-Mei
YM
Lai
I-Ching
IC
Liao
Ding-Lieh
DL
Chen
Jen-Yeu
JY
D000328:Adult; D000704:Analysis of Variance; D014150:Antipsychotic Agents / Q000009:adverse effects; D016009:Chi-Square Distribution; D004252:DNA Mutational Analysis; D020820:Dyskinesias / Q000209:etiology / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000235:genetics*; D011110:Polymorphism, Genetic; D011392:Proline / Q000235:genetics*; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy / Q000235:genetics*; D012694:Serine / Q000235:genetics*; D013624:Taiwan / Q000453:epidemiology
D014150:Antipsychotic Agents; D012694:Serine; D011392:Proline; D016660:NAD(P)H Dehydrogenase (Quinone); C447479:NQO1 protein, human